secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2024-03-26T23:59:59+00:00
Accession:  0001193125-24-077564
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotech raises $1.33M via private placement of common stock and warrants
-----------------------------------------------------------------------------

- Sold 578,643 shares at $2.295/share with warrants to purchase same number at $2.55.
- Warrants exercisable 6 months after issuance, 5-year term, no price protection.
- Proceeds to fund first third of THIO-101 trial Part C in non-small cell lung cancer.
- Closing expected on or about March 28, 2024, subject to customary conditions.
- Shares and warrants issued as restricted securities under Rule 144.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000119312524077564/0001193125-24-077564-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000119312524077564/d776139d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-077564

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer